Biocon Hits 52-Week High After ₹3,676 Crore Deal. Know Details


    By Dalal Street Investment Journal (DSIJ)

    Summary :

     

    Biocon share price surged over 7% on Tuesday after a ₹3,676 crore block deal marked Mylan's complete exit from the company. The rally was further supported by expectations that Biocon could be upgraded to the MSCI India Standard Index during the August review, boosting investor sentiment.

    Biocon Hits 52-Week High After ₹3,676 Crore Deal. Know Details

    Biocon came into the limelight during early trade on Tuesday after a large block deal worth around ₹3,676 crore. The buying interest strengthened further as investors also looked at the company as a strong contender for an upgrade in the upcoming MSCI index review.

    The positive sentiment pushed the stock to a fresh 52-week high during the session. It also emerged as the top gainer in the Nifty 500 index.

    Mylan Exits Biocon Through Block Deal

    Around 9.19 crore shares changed hands in the block deal at nearly ₹400 per share. As per NDTV Profit, the total deal value stood at about ₹3,676 crore ($363 million), making it the largest block transaction for the day.

    Market participants believe the shares were sold by Mylan. The company held a 5.64% stake in Biocon as of June 2026. With this transaction, Mylan has completely exited the biotechnology company, bringing its long-standing shareholding to an end.

    Biocon Limited

    Trade

    435.924.94 (6.06 %)

    Updated - 14 July 2026
    444.50day high
    DAY HIGH
    422.20day low
    DAY LOW
    11037270
    VOLUME (BSE)

    MSCI Inclusion Expectations Support Sentiment

    Apart from the block deal, investors are also tracking the upcoming MSCI index review. The official MSCI index review announcement is scheduled for August 12 after market hours. Any changes announced during the review will become effective from August 31.

    Market participants believe Biocon is among the high-probability candidates for an upgrade from the MSCI India Small Cap Index to the MSCI India Standard Index. The company is believed to have met the required market capitalisation and liquidity criteria after the recent improvement in both metrics. If the upgrade goes through, it could result in fresh passive fund inflows into the stock.

    Biocon Ltd Share Price Performance

    Following these developments, its share price opened 3.99% higher at ₹427.35 against its previous close of ₹410.95. Buying continued in the morning session, helping the stock hit an intraday high of ₹442.90. At its day's high, the stock had gained about 7.8% over the previous closing price and also made a fresh 52-week high.

    As of 11:00 am, the shares were trading at ₹441.80, up nearly 7.5%.

    In the past, the stock is up more than 13% in 2026 so far and has gained over 16% during the last one year.

    About Biocon Ltd

    Biocon Ltd is a global biopharmaceutical company focused on developing affordable healthcare products and specialised services. Its business spans biosimilars, generics, contract development and manufacturing services, and novel biologics.

    Source: Dalal Street Investment Journal (DSIJ), BSE, NSE

    About the Author

    SEBI Registered Research Analyst (INH000006396).


    Founded in 1986, Dalal Street Investment Journal (DSIJ) brings decades of experience in India’s equity markets. DSIJ's research combines fundamental analysis with price action, guided by disciplined risk management and capital preservation. They follow a structured, data-driven approach designed to help investors and traders make informed decisions beyond short-term market noise. 

    Published Date : 14 Jul 2026

    Disclaimer :

    Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

    The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

    The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

    Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

    BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.


    Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited



    This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing. 

    For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

    Read More Blogs

    Our Secure Trading Platforms

    Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

    QR code to download Bajaj Broking App

    9 lakh+ Users

    icon-with-text

    4.9 App Rating

    icon-with-text

    4 Languages

    icon-with-text

    ₹7,300 Cr+ MTF Book

    icon-with-text